We are live on
!
Find out more
GCP
GSA Capital Partners Portfolio holdings
AUM
$1.59B
1-Year Est. Return
39.81%
This Fund
S&P 500
This Quarter
Est. Return
+33.48%
1 Year Est. Return
+39.81%
3 Year Est. Return
+94.75%
5 Year Est. Return
+73.44%
10 Year Est. Return
+404.29%
AUM
$611M
AUM Growth
+$11.7M
(+2%)
Cap. Flow
-$91.9M
Cap. Flow
% of AUM
-15.04%
Top 10 Holdings %
Top 10 Hldgs %
4.77%
Holding
1,794
New
573
Increased
263
Reduced
313
Closed
643
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Best Buy
BBY
|
+$2.79M |
| 2 |
Bath & Body Works
BBWI
|
+$2.78M |
| 3 |
Advanced Micro Devices
AMD
|
+$2.7M |
| 4 |
NVIDIA
NVDA
|
+$2.4M |
| 5 |
ExxonMobil
XOM
|
+$2.28M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$10.9M |
| 2 |
State Street SPDR Bloomberg High Yield Bond ETF
JNK
|
+$7.99M |
| 3 |
ORPH
Orphazyme A/S
ORPH
|
+$5.06M |
| 4 |
BridgeBio Pharma
BBIO
|
+$3.35M |
| 5 |
BPY
Brookfield Property Partners L.P. Limited Partnership Units
BPY
|
+$3.25M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 17.42% |
| 2 | Technology | 16.03% |
| 3 | Healthcare | 14.17% |
| 4 | Industrials | 13.91% |
| 5 | Financials | 11.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
351
Astrana Health
ASTH
$1.77B
| $569K | 0.09% |
31,128
+11,755
| +61% | +$211K |
|
|
SF
352
Stifel
SF
$12.6B
| $567K | 0.09% |
16,857
-16,947
| -50% | -$503K |
|
|
SAFM
353
DELISTED
Sanderson Farms Inc
SAFM
| $566K | 0.09% |
+4,280
| New | +$565K |
|
354
Quest Diagnostics
DGX
$26.3B
| $565K | 0.09% |
+4,742
| New | +$578K |
|
355
ABM Industries
ABM
$2.84B
| $564K | 0.09% |
14,900
+8,606
| +137% | +$326K |
|
|
CMD
356
DELISTED
Cantel Medical Corporation
CMD
| $563K | 0.09% |
7,142
-7,575
| -51% | -$444K |
|
357
Telephone and Data Systems
TDS
$3.75B
| $562K | 0.09% |
30,255
-37,891
| -56% | -$696K |
|
358
Box
BOX
$4.6B
| $561K | 0.09% |
31,086
-88,719
| -74% | -$1.55M |
|
|
SAGE
359
DELISTED
Sage Therapeutics
SAGE
| $561K | 0.09% |
6,487
+1,743
| +37% | +$128K |
|
360
Sensient Technologies
SXT
$5.53B
| $561K | 0.09% |
7,606
-21,558
| -74% | -$1.5M |
|
|
NATI
361
DELISTED
National Instruments Corp
NATI
| $561K | 0.09% |
+12,772
| New | +$477K |
|
|
BPMC
362
DELISTED
Blueprint Medicines
BPMC
| $558K | 0.09% |
+4,973
| New | +$524K |
|
363
Hope Bancorp
HOPE
$1.79B
| $558K | 0.09% |
51,175
-51,951
| -50% | -$484K |
|
|
VNTR
364
DELISTED
Venator Materials PLC
VNTR
| $558K | 0.09% |
168,655
-11,982
| -7% | -$28.6K |
|
|
CFRX
365
DELISTED
ContraFect Corporation
CFRX
| $556K | 0.09% |
1,376
+493
| +56% | +$213K |
|
366
Midland States Bancorp
MSBI
$695M
| $555K | 0.09% |
31,044
-24,270
| -44% | -$396K |
|
367
Booz Allen Hamilton
BAH
$9.15B
| $552K | 0.09% |
6,333
+3,666
| +137% | +$312K |
|
368
Danaher
DHR
$144B
| $548K | 0.09% |
+2,781
| New | +$558K |
|
|
IVC
369
DELISTED
Invacare Corporation
IVC
| $548K | 0.09% |
61,245
-22,836
| -27% | -$190K |
|
370
OFG Bancorp
OFG
$2.21B
| $547K | 0.09% |
29,503
+1,611
| +6% | +$26K |
|
|
WBA
371
DELISTED
Walgreens Boots Alliance
WBA
| $547K | 0.09% |
+13,706
| New | +$531K |
|
372
Piper Sandler
PIPR
$5.29B
| $545K | 0.09% |
21,624
-22,424
| -51% | -$509K |
|
373
iShares Russell 3000 ETF
IWV
$20.3B
| $544K | 0.09% |
+2,433
| New | +$511K |
|
|
TCON
374
DELISTED
TRACON Pharmaceuticals, Inc. Common Stock
TCON
| $543K | 0.09% |
2,319
-1,765
| -43% | -$246K |
|
375
GrafTech
EAF
$212M
| $542K | 0.09% |
5,083
+3,984
| +363% | +$320K |
|
Similar funds
NCL
DG
VNT
SS
GWANC
LCM
LCM
FDCP
GSA Capital Partners's Q4 2020 Portfolio in Review
As of Q4 2020, GSA Capital Partners held 1,794 positions worth $611M, up 2% from $600M the previous quarter. Its ten largest holdings account for 4.8% of the portfolio.
GSA Capital Partners withdrew a net $91.9M in Q4 2020, closing 643 positions and reducing 313 holdings. Its most notable exit was iShares iBoxx $ High Yield Corporate Bond ETF, an estimated $10.9M position sold in full.
By sector, the portfolio is most concentrated in Consumer Discretionary at 17% of assets, up from 16% a quarter earlier, followed by Technology and Healthcare.
Against the trend, GSA Capital Partners opened a new position in Best Buy worth $2.49M.
- GSA Capital Partners's largest Q4 2020 buy was Best Buy: 24,945 shares worth $2.49M.
- GSA Capital Partners added most to Advanced Micro Devices in Q4 2020, an estimated $2.7M increase.
- GSA Capital Partners's biggest Q4 2020 reduction was BridgeBio Pharma, cutting an estimated $3.35M.
- GSA Capital Partners fully exited iShares iBoxx $ High Yield Corporate Bond ETF in Q4 2020, selling an estimated $10.9M.
- GSA Capital Partners's ten largest holdings make up 4.8% of its $611M portfolio in Q4 2020.
- GSA Capital Partners opened 573 new positions and closed 643 in Q4 2020.
- GSA Capital Partners's portfolio value rose 2% quarter-over-quarter to $611M.
Based on GSA Capital Partners's 13F filing for Q4 2020, filed 3 Feb 2021.